Welcome to the HDCRC

Our mission is to provide quality HD care, services, and education to patients, families, and community professionals; to increase awareness of HD in entire communities; and to conduct research contributing to future treatments or cures.

Subscribe to our newsletter now and get:

  • Clinical trial updates
  • HD resource packets
  • Local event information

ScienceDaily News 

  Outline bulletpoint iconNew data network for Huntington's disease research8/22/2017
 The first data network for research into Huntington's disease has been created by an international team, now freely available to all scientists in thi...Read More

  Outline bulletpoint iconGenetic modifier for Huntington's disease progression identified8/22/2017
 Researchers have developed a novel measure of disease progression for Huntington's disease, which enabled them to identify a genetic modifier associat...Read More

At Risk for HD Blog


  Outline bulletpoint iconIonis Huntington’s disease drug a step closer to a critical Phase 2 study6/27/2017
 Ionis Pharmaceuticals has made two positive announcements about the historic Phase 1 clinical trial of its gene-silencing drug for Huntington’s diseas...Read More

  Outline bulletpoint iconJoin the Facebook Live event (soon!) on Pope Francis’s historic audience with Huntington’s disease families5/30/2017
 I want to invite the Huntington’s disease community – and all potential new supporters of the cause – to participate in my Facebook Live interview abo...Read More

  Outline bulletpoint iconFrancis made a day of ‘superlatives’ for the Huntington’s disease community, says event co-organizer5/21/2017
 Pope Francis created a moment of “superlatives” for the Huntington’s disease community in his historic May 18 meeting with HD-afflicted families, inte...Read More

HDBuzz News


  Outline bulletpoint iconA step forward for gene editing: CRISPR-Cas9 and HD7/26/2017
 CRISPR-Cas9 is an experimental gene editing technique used to make precise changes in DNA. For the first time, scientists have used this approach to a...Read More

  Outline bulletpoint iconUpdate confirms Huntington's disease 'gene silencing' trial on track6/22/2017
 Ionis Pharmaceuticals launched the first ever trial of a huntingtin-lowering drug – sometimes called a 'gene silencing drug' – in late 2015. I...Read More

Our Services 

Medical Services

The GHPP Clinic is staffed by a multidisciplinary team of medical professionals who specialize in the diagnosis and treatment of persons affected with HD. The team includes neurologists, a psychiatrist, clinical nurse specialist, neuropsychologists, a social worker, center coordinator, and dietician. Clinic visits include complementary scheduling for physical therapy, occupational therapy, speech and swallowing evaluations, mobility equipment referrals, and other recurring services.

Family and Caregiver Support

The HDCRC provides services that address issues relating to the care of someone with HD. Assistance may include: general information and referrals, providing education and educational materials, support groups, genetic counseling, placement issues, in-service trainings in care facilities upon request of family member or care facility.

Genetic Testing and Counseling

The HDCRC assists individuals at-risk for inheriting HD, who have made a decision to be tested or are contemplating being tested for the HD gene mutation. Individuals are screened and counseled for issues such as: ability to cope with positive or negative results, relationships with family and friends, insurance planning, marriage and/or family planning, legal issues, career decisions, and support system.

Professional and Community Outreach

The goals of our professional education program are to expose healthcare professionals, police officers, school counselors, social workers, and other community members to a multidisciplinary approach to the care and needs of HD patients, to broaden their perspective, and to make them aware of the problems in caring for patients with HD, which lie outside of their traditional fields. Consultation and educational opportunities are provided to community professionals caring for patients and families affected by HD.

Research

The HDCRC is active in clinical HD research. Participants include those affected with HD, individuals at-risk for HD, family members or friends, and volunteer research subjects. Studies include clinical drug trials, observational trials, neuropsychological studies, and genetic research.

Our Center News 

UCSD Named Center of Excellence

UC San Diego is one of only 29 centers nationwide to receive prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research.

Read More

First Laquinimod Patient Enrolled

UC San Diego enrolls the world’s first patient in the LEGATO-HD trial, which explores an investigational multiple sclerosis drug for its potential to improve Huntington’s disease.

Read More

Clinical Trials


Please contact Jody Corey-Bloom, MD, PhD, at (858) 249-0568 or jcoreybloom@ucsd.edu to confirm clinical trial or study availability and/or to get further information about current trials or studies.

Huntington's Disease


 

Our Location


Huntington's Disease Clinical Research Center
at the Shiley-Marcos ADRC
9444 Medical Center Dr., Suite 1-100
La Jolla, CA 92037

Tel: (858) 249-0568
Fax: (858) 249-0573

HDSA Center of Excellence